News
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
A federal judge in Texas removed a Biden-era finalized ruled by the Consumer Financial Protection Bureau that would have ...
A Sun Pharmaceutical plant in India that has been repeatedly cited by the FDA for serious quality control issues failed another inspection last month.
A new large study from Denmark finds no evidence that aluminum salts used in vaccines are tied to a higher risk of childhood ...
Numerous service and staffing cuts at IHS facilities nationally have been caused by a new HHS contract review process, ...
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
Now, though, there are some bipartisan health care policies, from pharmacy-benefit manager reform to Medicare doctor payment ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
As FDA kicked off the drug user fee reauthorization process, Commissioner Marty Makary said he’d like to see lower fees paid ...
“I was very encouraged by the data, particularly for asthma as I know vaccine hesitancy groups are concerned by this,” Anna ...
I worked for 20 years for the HHS office that safeguarded people in research studies. DOGE gutted it
With fewer human research protection program staff in research institutions, mistakes will be made, and no one might be there ...
A well-placed biotech investor says U.S. policies are straining life sciences startups — and more disruption is coming.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results